| Schedule of segment and corporate information |
Segment and corporate information in € K | | | | | | | | | | | | | | | | | Care | | Value- | | Care | | Total | | Inter-segment | | | | | | | Delivery | | Based Care | | Enablement | | Segment | | eliminations | | Corporate | | Total | Three months ended March 31, 2026 | | | | | | | | | | | | | | | Revenue from healthcare services(1) | | 3,101,156 | | 43,351 | | — | | 3,144,507 | | — | | — | | 3,144,507 | Revenue from healthcare products(1) | | 71,533 | | — | | 930,354 | | 1,001,887 | | — | | — | | 1,001,887 | Revenue from contracts with customers(1) | | 3,172,689 | | 43,351 | | 930,354 | | 4,146,394 | | — | | — | | 4,146,394 | Revenue from insurance contracts(1) | | — | | 447,019 | | — | | 447,019 | | — | | — | | 447,019 | Revenue from lease contracts(1) | | — | | — | | 18,734 | | 18,734 | | — | | — | | 18,734 | Revenue from external customers | | 3,172,689 | | 490,370 | | 949,088 | | 4,612,147 | | — | | — | | 4,612,147 | Inter-segment revenue | | 120,879 | | — | | 349,905 | | 470,784 | | (470,784) | | — | | — | Revenue | | 3,293,568 | | 490,370 | | 1,298,993 | | 5,082,931 | | (470,784) | | — | | 4,612,147 | Costs of revenue | | (2,546,586) | | (451,386) | | (886,078) | | (3,884,050) | | 449,333 | | 2,062 | | (3,432,655) | Research and development | | — | | — | | (38,230) | | (38,230) | | — | | (79) | | (38,309) | Operating income (loss) | | 271,188 | | (11,038) | | 87,269 | | 347,419 | | (21,451) | | (39,773) | | 286,195 | Interest | | | | | | | | | | | | | | (78,679) | Income before income taxes | | | | | | | | | | | | | | 207,516 | Depreciation and amortization | | (232,438) | | (658) | | (117,373) | | (350,469) | | 10,050 | | (13,483) | | (353,902) | Impairment loss | | (69,869) | | — | | (3,951) | | (73,820) | | — | | (35,220) | | (109,040) | Income (loss) from equity method investees | | 41,322 | | — | | — | | 41,322 | | — | | — | | 41,322 | Total assets(1) | | 40,689,509 | | 615,079 | | 14,221,275 | | 55,525,863 | | (35,520,928) | | 11,462,658 | | 31,467,593 | thereof investment in equity method investees(1) | | 701,400 | | — | | — | | 701,400 | | — | | — | | 701,400 | Additions of property, plant and equipment, intangible assets and right-of-use assets(1) | | 202,666 | | 38 | | 118,241 | | 320,945 | | (27,498) | | 24,371 | | 317,818 | | | | | | | | | | | | | | | | Three months ended March 31, 2025 | | | | | | | | | | | | | | | Revenue from healthcare services(1) | | 3,250,182 | | 26,131 | | — | | 3,276,313 | | — | | — | | 3,276,313 | Revenue from healthcare products(1) | | 77,562 | | — | | 1,001,629 | | 1,079,191 | | — | | — | | 1,079,191 | Revenue from contracts with customers(1) | | 3,327,744 | | 26,131 | | 1,001,629 | | 4,355,504 | | — | | — | | 4,355,504 | Revenue from insurance contracts(1) | | — | | 503,360 | | — | | 503,360 | | — | | — | | 503,360 | Revenue from lease contracts(1) | | — | | — | | 22,590 | | 22,590 | | — | | — | | 22,590 | Revenue from external customers | | 3,327,744 | | 529,491 | | 1,024,219 | | 4,881,454 | | — | | — | | 4,881,454 | Inter-segment revenue | | 119,085 | | — | | 342,713 | | 461,798 | | (461,798) | | — | | — | Revenue | | 3,446,829 | | 529,491 | | 1,366,932 | | 5,343,252 | | (461,798) | | — | | 4,881,454 | Costs of revenue | | (2,739,629) | | (492,629) | | (922,255) | | (4,154,513) | | 456,481 | | 556 | | (3,697,476) | Research and development | | — | | — | | (43,482) | | (43,482) | | — | | — | | (43,482) | Operating income (loss) | | 319,997 | | 3,249 | | 94,301 | | 417,547 | | (5,317) | | (80,840) | | 331,390 | Interest | | | | | | | | | | | | | | (80,737) | Income before income taxes | | | | | | | | | | | | | | 250,653 | Depreciation and amortization | | (260,606) | | (1,241) | | (114,546) | | (376,393) | | 10,836 | | (17,040) | | (382,597) | Impairment loss | | (7,076) | | (2,274) | | (2,416) | | (11,766) | | — | | — | | (11,766) | Income (loss) from equity method investees | | 47,833 | | — | | — | | 47,833 | | — | | — | | 47,833 | Total assets(1) | | 41,736,877 | | 893,061 | | 14,487,213 | | 57,117,151 | | (35,342,632) | | 10,960,515 | | 32,735,034 | thereof investment in equity method investees(1) | | 666,752 | | — | | — | | 666,752 | | — | | — | | 666,752 | Additions of property, plant and equipment, intangible assets and right-of-use assets(1) | | 209,736 | | 107 | | 112,285 | | 322,128 | | (9,837) | | 5,417 | | 317,708 |
(1) | These line items are included to comply with requirements under IFRS 8 and IFRS 15 or are provided on a voluntary basis, but not included in the information regularly reviewed by the chief operating decision maker. |
|